Identification and molecular characterization of the first complete genome sequence of Human Parechovirus type 15

Maria Dolores Fernandez-Garcia1, Etienne Simon-Loriere2, Ousmane Kebe3

  • 1Institut Pasteur, Dakar, Senegal. dolores.fernandez@yahoo.es.

Scientific Reports
|April 23, 2020
PubMed

Insights

This study presents the first full-length genome of human parechovirus type 15 (HPeV15), identified in a child with acute flaccid paralysis. The findings reveal potential genomic recombination and contribute crucial data on HPeV15 evolution.

Area of Science:

  • Virology
  • Genomics
  • Molecular Epidemiology

Background:

  • Human parechoviruses (HPeVs) are emerging viral pathogens.
  • HPeV15 is a rarely reported type with limited genomic data available.
  • Previous studies lacked full-length HPeV15 genome sequences in public databases.

Purpose of the Study:

  • To determine the first full-length genome sequence of a human parechovirus type 15 (HPeV15) strain.
  • To analyze the genomic characteristics and evolutionary relationships of HPeV15.
  • To contribute to understanding HPeV diversity and epidemiology, particularly in Africa.

Main Methods:

  • Metagenomics sequencing to obtain the full-length viral genome.
  • Comparative analysis of VP1 nucleotide and amino acid sequences.
  • Phylogenetic analysis using P2 and P3 coding regions.
  • Similarity plot analysis to detect recombination events.

Main Results:

  • The first complete genome sequence of an HPeV15 strain was determined.
  • The strain showed 79.6% nucleotide and 93.4% amino acid identity to the HPeV15 prototype in VP1.
  • Phylogenetic analysis indicated low identity to other HPeV types and suggested potential intertypic recombination with HPeV3.
  • Genomic recombination events may have occurred in the UTRs and nonstructural regions.

Conclusions:

  • This study provides the first full-length HPeV15 genome, significantly expanding available data.
  • Genomic recombination is suggested as a factor in HPeV15 evolution.
  • The findings enhance understanding of HPeV diversity and epidemiology in Africa.